{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "111.00",
    "chg": -2.35,
    "chgp": "-2.07%",
    "dir": -1,
    "prev_price": "113.35",
    "mcapval": "270.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE878I01022",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "2.39 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 253,
    "sid": "852453",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome For Board Meeting Held On 27/03/2026",
      "datetime": "27-Mar-2026",
      "details": "The Board of Directors of the Company in the Meeting held on March 27 2026 has inter-alia considered and approved: (i) The appointment of M/s. K. S. Rao & Co. Chartered Accountants Chennai as the Internal Auditor of the Company for the Financial Year 2026-2027; (ii) The appointment of M/s. N. Sivashankaran & Co. Cost Accountants Chennai as the Cost Auditor of the Company for the Financial Year 2026-2027.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation for Closure of Trading Window.",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Price Movement",
      "datetime": "24-Mar-2026",
      "details": "We hereby submit our response to the clarification sought by the Stock Exchange regarding the movement in the share price of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News